ECM Booster · hADM
Elravie Re2O in Seoul | 4th-Generation ECM Booster (hADM)
Re2O is the 4th generation of skin boosters — the only injectable that replenishes real human extracellular matrix (hADM) directly into the dermis, rather than stimulating the skin to produce collagen indirectly. Launched in 2024 by Humedix, it is processed with patented AlloClean technology to remove all cellular and lipid fractions that could trigger immune response.
Overview
Elravie Re2O in Seoul — the world's first ECM booster using human-derived dermal matrix (hADM) from Humedix Korea for direct structural skin restoration.
- Skin aging with visible ECM structural loss — laxity, thinning, crepey texture
- Plateau after conventional PN (Rejuran) or HA boosters
- Post-procedure recovery after RF microneedling, laser, or HIFU
- Periorbital and delicate zones where structural rebuilding is preferred over volume
Who This Page Helps
Use this page to decide whether this treatment belongs in your shortlist.
The goal here is not to push a booking, but to help you decide whether this treatment fits your concerns and timing.
How Planning Usually Works
This is the order many patients find easiest to follow.
It is usually more useful to start from your current condition, schedule, and priorities than from a device or product name alone.
- 1
Dermatologist evaluates skin density, ECM loss pattern, and treatment goals
- 2
Topical anesthesia is applied; injection plan is mapped for serial puncture, linear threading, or cannula in delicate zones
- 3
hADM microparticles (150 mg) are injected into the deep dermis across the treatment area
- 4
Session takes approximately 20-30 minutes
- 5
Papules and mild embossing resolve within 2-3 days; makeup from the following day
Why Specialist Review Matters
Diagnosis and treatment order often matter more than the treatment name itself.
Two concerns can look similar at first, but require a different plan once a dermatologist reviews them carefully.
hADM is a human-origin allograft — injection depth and technique directly determine how the ECM scaffold integrates with native tissue
A board-certified dermatologist can assess whether Re2O, PN (Rejuran), PDLLA (Juvelook), or HA is the correct generation of booster for your specific skin
Combination protocols with Potenza, Ulthera, Thermage, or SKINVIVE require careful sequencing to maximize the regenerative cascade
Visit and Timing Notes
These points are worth reviewing together with your Seoul schedule.
It helps to think about timing, recovery, and treatment order together instead of looking only at one procedure in isolation.
Minimal downtime — papules and embossing resolve within 2-3 days; bruising (if any) within 1-2 days
Cleansing from 3 hours post-procedure; makeup from the following day
Immediate structural improvement; peak results at 4-8 weeks; 3 sessions at 3-4 week intervals for optimal outcome
FAQ
Common questions patients ask before they contact the clinic.
These answers are meant to make comparison and consultation prep a little clearer.
How is Re2O different from Rejuran, Juvelook, or regular HA boosters?
Re2O is the 4th generation — it directly replenishes extracellular matrix using human-derived hADM. Rejuran (2nd gen, salmon PDRN) and Juvelook (3rd gen, PDLLA) stimulate the skin to produce collagen indirectly. HA boosters (1st gen) provide immediate hydration only. Re2O is the first to rebuild the actual structural matrix of the dermis rather than triggering a stimulation pathway.
Is hADM safe? It comes from human tissue.
The hADM raw material has FDA approval and has been used for years in surgical tissue reconstruction before its aesthetic application. Patented AlloClean technology removes all cellular and lipid fractions that could trigger immune or rejection responses, leaving a pure, acellular ECM scaffold. Because ECM naturally exists in the human body, the skin recognizes Re2O as 'self' — not as a foreign implant.
How soon can I see results?
The injected ECM provides immediate physical scaffolding — you may see skin density and texture improvement after a single session. As the matrix gradually degrades over weeks, it signals fibroblast activation and new collagen/elastin synthesis. Peak results are typically observed at 4-8 weeks, with clinical studies confirming sustained elasticity improvement after a 3-session course.
Related Procedures
These procedures are often compared with Elravie Re2O.
If one procedure does not answer the whole question yet, comparing the pages below usually helps.
Related Guides
These guides help patients compare or prepare for Elravie Re2O.
Use the related guides to sort out comparison points and visit planning before you decide.
Notice: Individual results may vary depending on skin condition, treatment history, and recovery factors. All treatment plans are determined through individual consultation with a board-certified dermatologist. The information on this page is for reference only and does not constitute medical advice or guarantee specific outcomes.
Next Step